台股 » 個股 » 錦明 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

錦明

(3230)
  • 股價
    15.25
  • 漲跌
    ▼0.15
  • 漲幅
    -0.97%
  • 成交量
    410
  • 產業
    上櫃 光電類股
  • 32人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
錦明 (3230)籌碼相關-第一金-嘉義 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

第一金-嘉義 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2024/06/2500.00114.8015.40-11,021-0.10%
2024/06/1900.00116.5016.45-11,000-0.10%
2024/06/03116.653016.6516.65-29869-3.34%
2024/05/31115.2500.0015.1518380.12%
2024/05/2900.00215.7016.15-2835-0.24%
2024/05/2800.00514.9014.70-5802-0.62%
2024/05/2200.00215.0014.80-2801-0.25%
2024/05/21914.5900.0014.5597941.13%
2024/05/17416.6000.0016.5048090.49%
2024/05/16616.3200.0016.8067880.76%
2024/05/146415.5500.0015.55647118.99%
2024/05/10413.7600.0013.6046370.63%
2024/03/1400.00110.5010.35-1477-0.21%
2024/03/0700.00011.7011.3504570.00%
2024/03/0600.00012.0011.8004510.00%
2024/03/0500.001012.3012.30-10440-2.27%
2024/03/01511.0000.0010.8554081.22%
2024/02/27511.4000.0011.3554101.22%
2024/02/21112.9000.0012.5514160.24%
2024/02/2000.001012.7613.40-10388-2.58%
2024/02/021011.8500.0011.45103003.33%
2023/06/27313.45313.5013.5502840.00%
2023/05/151014.9500.0014.75102943.40%
2023/05/1200.00314.6515.00-3292-1.03%
2023/05/11315.2800.0014.9032891.04%
2022/09/12415.66415.9315.8003070.00%
2022/05/26217.60217.2517.5503190.00%
2022/04/20019.0000.0018.6003380.00%
2022/04/11018.5000.0017.8003430.00%
2022/04/071818.211818.2918.1003330.00%
2022/03/31616.88616.8317.4502700.00%
2022/03/291516.591516.8817.4002420.00%
2021/09/231822.531821.8021.3001,0860.00%
2021/09/1500.00323.0022.70-3960-0.31%
2021/09/14121.75121.0521.7008520.00%
2021/09/07219.10219.4519.6007030.00%
2021/08/311019.451019.6019.2004680.00%
2021/08/2400.00116.9016.85-1387-0.26%
2021/08/23117.0000.0017.1513820.26%
2021/07/23317.4000.0017.4033570.84%
2021/04/0900.00123.5023.95-1575-0.17%
2021/03/25117.000.517.5018.000.53390.13%
2021/03/1618.2500.008.1712690.37%
2020/09/1600.0026.826.88-2329-0.61%
2020/09/0926.8600.006.9021941.03%
寶齡富錦明日停牌 傳將公布腎臟新藥中國三期臨床結果Anue鉅亨-2022/02/21
錦明 相關文章
錦明 相關影音